Clinical Utility of Selinexor/Dexamethasone in Patients with Relapsed or Refractory Multiple Myeloma: A Review of Current Evidence and Patient Selection

Panagiotis Malandrakis,* Ioannis Ntanasis-Stathopoulos,* Maria Gavriatopoulou, Evangelos Terpos Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece*These authors contributed equally to this workCorrespondence: Evangelos TerposDepart...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Malandrakis P, Ntanasis-Stathopoulos I, Gavriatopoulou M, Terpos E
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2020-07-01
Colecção:OncoTargets and Therapy
Assuntos:
selinexor
exportin
selective inhibitor of nuclear export
relapsed/refractory
myeloma
Acesso em linha:https://www.dovepress.com/clinical-utility-of-selinexordexamethasone-in-patients-with-relapsed-o-peer-reviewed-article-OTT
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados